Optiray (Ioversol)

Optiray is an iodinated contrast agent used in diagnostic imaging procedures to improve visualization of anatomical structures.

• Vascular imaging (angiography): enhances visualization of blood vessels during angiographic studies.
• Computed tomography (CT) imaging: provides contrast enhancement for clearer CT images of organs and tissues.
• Urography: improves delineation of urinary tract structures during contrast‑enhanced examinations.
• Contrast‑enhanced radiographic procedures: facilitates better imaging of various body parts in radiography.

• Ioversol contains multiple iodine atoms that strongly attenuate X‑rays. When administered intra‑arterially or intravenously, it distributes within the vascular and extracellular compartments, creating areas of high radiodensity. This radiopaque contrast highlights vessels, organs, and tissues, allowing enhanced differentiation on X‑ray, CT, and fluoroscopic imaging, thereby improving diagnostic interpretation.

Adverse reactions may occur following administration of iodinated contrast agents.

Common Side Effects

• Warmth or flushing sensation during injection.
• Metallic taste in the mouth.
• Nausea or mild vomiting.
• Headache or dizziness.
• Mild injection site pain or bruising.
• Transient increase in serum creatinine.

Serious or Rare Side Effects

• Severe allergic reactions, including anaphylaxis.
• Acute kidney injury, especially in patients with pre‑existing renal impairment.
• Cardiovascular collapse or severe hypotension.
• Seizures or neurologic disturbances.
• Pulmonary edema or respiratory distress.

Prior to using Optiray, certain precautions should be observed to minimize risk.

• Renal function: assess baseline kidney function and consider hydration in at‑risk patients.
• Allergy history: evaluate for prior reactions to iodinated contrast agents.
• Thyroid status: monitor patients with hyperthyroidism or thyroid disorders.
• Metformin therapy: suspend metformin in patients with reduced renal function before and after administration.
• Pregnancy and lactation: use only if clearly necessary after risk‑benefit assessment.
• Store at ambient temperature: keep in original container, protect from light and moisture.

Ioversol may interact with other medications, requiring careful management.

Major Interactions (Avoid)

• Metformin: risk of lactic acidosis in patients with renal impairment; consider temporary discontinuation.
• Nephrotoxic drugs (e.g., aminoglycosides, NSAIDs): may exacerbate renal toxicity when combined with contrast.
• Thyroid hormones: iodinated contrast can affect thyroid function tests and hormone levels.

Moderate Interactions (Monitor Closely)

• Diuretics: may increase risk of dehydration and renal injury.
• ACE inhibitors or ARBs: monitor blood pressure and renal function.
• Other contrast agents: avoid sequential administration without adequate interval.
• Beta‑blockers: may mask signs of contrast‑induced hypertension.